Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History
22.11.2022 - Led by a Significant Increase in Duramed, Music City Botanical and Botanical Biotech Brands Adjusted EBITDA Loss Decreased by 25% to $1.5 Million HICKSVILLE, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) - via NewMediaWire – Can B Corp. (OTCQB: ... Seite 1
Source: wallstreet-online.de